Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketorolac tromethamine for acute treatment of migraine (Phase 2)
2007-001431-58Phase 2Completed
- Sponsor
- RoxRo Pharmaceuticals
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Intranasal ketorolac tromethamine with Intranasal placebo (2 arms). Primary endpoint: Pain-free at 2 hours. Started Apr 2007; status: completed.
02
Drugs
ketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on 2007-001431-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001431-58.